Is Intravesical Bacillus Calmette-Guérin Therapy Superior to Chemotherapy for Intermediate-risk Non-muscle-invasive Bladder Cancer?: An Ongoing Debate

The objective of this study was to evaluate the risk of recurrence in patients with intermediate-risk non-muscle-invasive bladder cancer (NMIBC) after intravesical instillation with chemotherapeutic agents or Bacillus Calmette-Guérin (BCG) therapy. A cohort of 746 patients with intermediate-risk NMI...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Kyung-Sik, You, Dalsan, Jeong, In Gab, Kwon, Teakmin, Hong, Bumsik, Hong, Jun Hyuk, Ahn, Hanjong, Ahn, Tai Young, Kim, Choung-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330478/
https://www.ncbi.nlm.nih.gov/pubmed/25729246
http://dx.doi.org/10.3346/jkms.2015.30.3.252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330478/
https://www.ncbi.nlm.nih.gov/pubmed/25729246
http://dx.doi.org/10.3346/jkms.2015.30.3.252

Ejemplares similares